Asset Manager

Updated:

Retina Consultants of America

Retina Consultants of America is a physician-led management platform backing retina specialists nationwide, offering business support and clinical trial...

Retina Consultants of America

Retina Consultants of America (RCA) was founded to consolidate and support independent retina practices to preserve specialist autonomy while adding operational scale. The firm presents itself as a physician-led organization where clinical decisions stay with the doctors and business resources are shared across the network. Wealth origin for the capital backing is not publicly disclosed. RCA focuses on retina-only ophthalmology, providing infrastructure for clinical trials, practice management, and patient experience streamlining. The network likely engages in M&A-like partnerships with retina practices nationwide, converting independent clinics into affiliates under a shared brand. Stateside coverage is cited, but no named portfolio companies or individual practices appear on the website. No fund structure, stage, or deal vehicles have been confirmed. The firm's team size, professional backgrounds, and total deployment remain undisclosed. RCA's website references an RCA Research arm that conducts clinical trials, but no further details – such as date of launch – are provided. No recent operational event in the past 24 months is verifiable from publicly available sources. A structural differentiator for RCA is its claim to be physician-led, meaning doctors retain clinical authority while RCA handles non-clinical operations. This distinguishes the firm from typical hospital-affiliated or private-equity-owned groups where physicians may lose autonomy. However, supporting detail on governance, succession, or ownership structure remains absent from the public record.

General information

Firm type

Asset Manager

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Southlake

Corporate office

Southlake, TX, United States

Sector focus

Healthcare Services

Frequently asked questions

Who runs investment decisions at Retina Consultants of America?

RCA has not publicly named its investment managers, CEO, or board. The firm's website presents itself as physician-led but omits named leadership, making the decision-making group unknown from public sources.

How does Retina Consultants of America source proprietary deal flow?

RCA likely sources partners through direct outreach to independent retina practices seeking operational support. No specific sourcing model (e.g., auctions or direct relationships) is disclosed on the firm's website.

Is Retina Consultants of America structured as a single family office or does it operate more like a venture firm?

RCA is neither a family office nor a venture firm. It functions as a management services organization (MSO) for retina specialists, employing a partnership model akin to a physician practice management platform.

Does Retina Consultants of America participate in fund commitments or only direct deals?

The firm does not disclose a fund strategy. Available information suggests RCA forms direct operational partnerships with retina practices, with no evidence of external fund management or third-party LP commitments.

What investment stages does Retina Consultants of America typically target?

RCA targets established retina practices ready for partnership and scale, rather than stage-based equity investments. The model resembles partnership acquisition for mature clinical businesses, not venture or growth equity stages.

Which sectors does Retina Consultants of America explicitly avoid?

The firm explicitly focuses solely on retina ophthalmology. No other medical specialties or non-healthcare sectors appear in its strategy. Avoided sectors are not formally listed.

Does Retina Consultants of America maintain philanthropic structures, and how are they separated?

RCA's website references an RCA Research arm for clinical trials, which may involve non-profit activities, but no separate foundation or philanthropic entity is disclosed. No separation details are available.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo